iGii and Prymexa agree multi-million deal to diagnose early signs of menopause with at-home toolkit
iGii partners with Prymexa on a multi-million-pound deal to develop a toolkit that monitors when a woman enters the perimenopause […]
News & Blogs
View All Posts
New highly sensitive saliva-based cortisol sensor developed – eliminating the need for invasive blood tests
Pioneering saliva-based point-of-care electrochemical biosensor developed for real-time cortisol tracking – avoiding the need for invasive blood tests. Underpinned by […]
iGii secures £8.8m investment to accelerate growth and scale manufacturing capability
iGii, announces £8.8m in new funding to accelerate growth. The Stirling-based company, formerly known as Integrated Graphene, will use the […]
University of Bath scientists develop new battery-free lactic acid sensor using Gii-Sens
Scientists at the University of Bath, UK, introduce breakthrough carbon-based sensor for detecting lactic acid levels in saliva – avoiding […]
iGii appoints Dr Jo Holmes to supercharge Gii-Sens growth
Dr. Jo Holmes has been appointed to spearhead sales of Gii-Sens, its world leading electrochemical electrode. With a distinguished background […]
iGii prepares for global manufacturing and increased international sales with appointment of new Chief Operating Officer
Andrew Lacey has been appointed to a newly-created position of Chief Operating Officer. Andrew will be responsible for developing Integrated […]
